Proove Biosciences Announces Expanding List of Proove Genetic Testing Providers Throughout Florida

IRVINE, Calif. - May 17, 2013 - PRLog -- Proove Biosciences, the leader in personalized pain medication innovation, is pleased to announce that five doctors and clinics throughout the Central and Southern Florida region will begin utilizing Proove’s suite of genetic tests, ensuring patients receive optimal treatment for their chronic pain conditions based on their specific genetic profile. The physician and clinic specialties range from rehabilitation and chiropractic care, to pain management.

“We are excited to see our services being utilized by more and more physicians throughout the South East. In Florida, the problem of prescription opiate abuse has been increasing far beyond the national average,” stated Brian Meshkin, President of Proove Biosciences. “Expanding our services here, and helping physicians better determine who may be susceptible to dependence and addiction is the mission Proove was founded on.”

The newest physicians and clinics in the Florida area began utilizing Proove’s genetic tests towards the end of March 2013. Proove is currently expanding throughout Florida, and is expecting to add several more clinics and physicians throughout the second quarter.

“The mission of Proove Biosciences is to help healthcare providers make better informed decisions on behalf of their patients using science and technology,” Meshkin added, “we have been in close contact with pain management and rehabilitation professionals in the last twelve months, and they understand the value Proove adds to their patients’ treatment. They have seen how our scientific research and technology helps ensure more effective patient outcomes through proven analysis of how they will respond to narcotic based pain medicines. It is an exciting time at Proove Biosciences, and we are looking forward to working with more doctors in helping to provide better outcomes for pain patients.”